Number of the records: 1  

Addiction to DUSP1 protects JAK2V617F-driven polycythemia vera progenitors against inflammatory stress and DNA damage, allowing chronic proliferation

  1. 1.
    SYSNO ASEP0523081
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleAddiction to DUSP1 protects JAK2V617F-driven polycythemia vera progenitors against inflammatory stress and DNA damage, allowing chronic proliferation
    Author(s) Stetka, J. (CZ)
    Vyhlidalova, P. (CZ)
    Láníková, Lucie (UMG-J)
    Koralkova, P. (CZ)
    Gursky, J. (CZ)
    Hlusi, A. (CZ)
    Flodr, P. (CZ)
    Hubáčková, Soňa (BTO-N)
    Bártek, Jiří (UMG-J) RID
    Hodný, Zdeněk (UMG-J) RID
    Divoky, V. (CZ)
    Number of authors11
    Source TitleOncogene. - : Springer - ISSN 0950-9232
    Roč. 38, č. 28 (2019), s. 5627-5642
    Number of pages16 s.
    Publication formOnline - E
    Languageeng - English
    CountryGB - United Kingdom
    Keywordsstem-cell function ; reactive oxygen ; replication stress ; oxidative stress ; hematopoietic progenitors ; ifn-gamma ; expression ; disease ; activation ; progression
    Subject RIVEB - Genetics ; Molecular Biology
    OECD categoryCell biology
    Subject RIV - cooperationInstitute of Biotechnology - Genetics ; Molecular Biology
    R&D ProjectsLTAUSA17142 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Method of publishingOpen access
    Institutional supportUMG-J - RVO:68378050 ; BTO-N - RVO:86652036
    UT WOS000474845100006
    DOI10.1038/s41388-019-0813-7
    AnnotationInflammatory and oncogenic signaling converge in disease evolution of BCR-ABL-negative myeloproliferative neoplasms, clonal hematopoietic stem cell disorders characterized by gain-of-function mutation in JAK2 kinase (JAK2V617F), with highest prevalence in patients with polycythemia vera (PV). Despite the high risk, DNA-damaging inflammatory microenvironment, PV progenitors tend to preserve their genomic stability over decades until their progression to post-PV myelofibrosis/acute myeloid leukemia. Using induced pluripotent stem cells-derived CD34(+) progenitor-enriched cultures from JAK2V617F(+) PV patient and from JAK2 wild-type healthy control, CRISPR-modified HEL cells and patients' bone marrow sections from different disease stages, we demonstrate that JAK2V617F induces an intrinsic IFN gamma- and NF-kappa B associated inflammatory program, while suppressing inflammation-evoked DNA damage both in vitro and in vivo. We show that cells with JAK2V617F tightly regulate levels of inflammatory cytokines-induced reactive oxygen species, do not fully activate the ATM/p53/p21waf1 checkpoint and p38/JNK MAPK stress pathway signaling when exposed to inflammatory cytokines, suppress DNA single-strand break repair genes' expression yet overexpress the dual-specificity phosphatase (DUSP) 1. RNAi-mediated knock-down and pharmacological inhibition of DUSP1, involved in p38/JNK deactivation, in HEL cells reveals growth addiction to DUSP1, consistent with enhanced DNA damage response and apoptosis in DUSP1inhibited parental JAK2V617F(+) cells, but not in CRISPR-modified JAK2 wild-type cells. Our results indicate that the JAK2V617F+ PV progenitors utilize DUSP1 activity as a protection mechanism against DNA damage accumulation, promoting their proliferation and survival in the inflammatory microenvironment, identifying DUSP1 as a potential therapeutic target in PV.
    WorkplaceInstitute of Molecular Genetics
    ContactNikol Škňouřilová, nikol.sknourilova@img.cas.cz, Tel.: 241 063 217
    Year of Publishing2020
    Electronic addresshttps://www.nature.com/articles/s41388-019-0813-7
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.